Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. 2020

Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
Division of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA.

The potent HIV-1 capsid inhibitor GS-6207 is an investigational principal component of long-acting antiretroviral therapy. We found that GS-6207 inhibits HIV-1 by stabilizing and thereby preventing functional disassembly of the capsid shell in infected cells. X-ray crystallography, cryo-electron microscopy, and hydrogen-deuterium exchange experiments revealed that GS-6207 tightly binds two adjoining capsid subunits and promotes distal intra- and inter-hexamer interactions that stabilize the curved capsid lattice. In addition, GS-6207 interferes with capsid binding to the cellular HIV-1 cofactors Nup153 and CPSF6 that mediate viral nuclear import and direct integration into gene-rich regions of chromatin. These findings elucidate structural insights into the multimodal, potent antiviral activity of GS-6207 and provide a means for rationally developing second-generation therapies.

UI MeSH Term Description Entries
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072417 Protein Domains Discrete protein structural units that may fold independently of the rest of the protein and have their own functions. Peptide Domain,Protein Domain,Domain, Peptide,Domain, Protein,Domains, Peptide,Domains, Protein,Peptide Domains
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016662 Virus Integration Insertion of viral DNA into host-cell DNA. This includes integration of phage DNA into bacterial DNA; (LYSOGENY); to form a PROPHAGE or integration of retroviral DNA into cellular DNA to form a PROVIRUS. Integration, Provirus,Integration, Virus,Provirus Integration,Viral integration,Integrations, Provirus,Integrations, Virus,Provirus Integrations,Viral integrations,Virus Integrations,integration, Viral,integrations, Viral
D041961 Deuterium Exchange Measurement A research technique to measure solvent exposed regions of molecules that is used to provide insight about PROTEIN CONFORMATION. Hydrogen-Deuterium Exchange Measurement,Deuterium Exchange Measurements,Exchange Measurement, Deuterium,Exchange Measurement, Hydrogen-Deuterium,Exchange Measurements, Deuterium,Exchange Measurements, Hydrogen-Deuterium,Hydrogen Deuterium Exchange Measurement,Hydrogen-Deuterium Exchange Measurements,Measurement, Deuterium Exchange,Measurement, Hydrogen-Deuterium Exchange,Measurements, Deuterium Exchange,Measurements, Hydrogen-Deuterium Exchange
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
January 2024, bioRxiv : the preprint server for biology,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
August 2012, The Journal of biological chemistry,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
January 2024, International journal of antimicrobial agents,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
January 2023, Science advances,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
January 2022, Current opinion in HIV and AIDS,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
September 2019, Nature medicine,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
May 2023, Antimicrobial agents and chemotherapy,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
April 2016, Antimicrobial agents and chemotherapy,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
January 2022, Frontiers in microbiology,
Stephanie M Bester, and Guochao Wei, and Haiyan Zhao, and Daniel Adu-Ampratwum, and Naseer Iqbal, and Valentine V Courouble, and Ashwanth C Francis, and Arun S Annamalai, and Parmit K Singh, and Nikoloz Shkriabai, and Peter Van Blerkom, and James Morrison, and Eric M Poeschla, and Alan N Engelman, and Gregory B Melikyan, and Patrick R Griffin, and James R Fuchs, and Francisco J Asturias, and Mamuka Kvaratskhelia
March 2007, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!